GenomSys
GenomSys is a Swiss health software company that commercializes the ISO/IEC 23092 MPEG-G standard, offering compression, storage, and analysis software for genomic data to diagnostic labs, blood transfusion centers, and national health systems.
- Company typePrivate
- Founded2016
- HeadquartersLausanne, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What GenomSys does
GenomSys SA is a Swiss health software company founded in 2016 and headquartered at the EPFL Innovation Park / Biopôle in Lausanne, with additional engineering and operations offices in Lugano, Milan, Turin, and Monza. The company builds and commercializes the only commercial implementation of the ISO/IEC 23092 MPEG-G international standard for genomic data, offering a unified software platform for compression, storage, selective access, transmission, and analysis of genomic information. Its product portfolio comprises the GenomSys MPEG-G Toolkit (SDK and command-line tools), the GenomSys Secondary Analysis Platform (cloud-based germline pipeline), the GenomSys Variant Analyzer (CE-marked desktop variant interpretation software integrated with Varsome), the GenomSys Blood Typer (NGS-based blood group characterization for transfusion medicine), and the GenomYou consumer mobile app for personal genomic data access.
GenomSys monetizes through a mix of one-time enterprise software licensing for the MPEG-G Toolkit, recurring subscriptions for the Variant Analyzer and Blood Typer desktop applications, private cloud deployments for large healthcare organizations, and exclusive regional distribution agreements (e.g., Genetics Company for Biotechnology in Jordan). The company sells via enterprise field sales with quote-based pricing and "Request a Trial" and "Schedule a Call" funnels, complemented by channel partners and OEM integrations with healthcare-IT platforms such as Philips Healthcare. It is ISO 13485-certified as a medical device software manufacturer and targets genomic diagnostic laboratories, blood transfusion centers, and national health systems across Europe, with recent expansion into the Middle East. Strategic technology and research collaborators include EPFL, the Italian Institute of Technology, Varsome, and SysMeta IT/Tangerine Medical. The company is privately held, venture-backed by a CHF 9.3 million Series A (led by Preon Capital in December 2020), and operates with a multicultural team of 11-50 employees.
GenomSys firmographics
Firmographics- Name
- GenomSys
- Legal name
- GenomSys SA
- Website
- https://genomsys.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- GenomSys is a Swiss health software company that commercializes the ISO/IEC 23092 MPEG-G standard, offering compression, storage, and analysis software for genomic data to diagnostic labs, blood transfusion centers, and national health systems.
- Ownership category
- akta.pro rank
GenomSys industry classification
Industry- Product category
- Genomic Data Management Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)
- akta.pro secondary industries
- Population Genomics & Preventive Precision Health Programs (HLAAANAL), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
Keywords
Where GenomSys is headquartered
LocationHeadquarters
- HQ city
- Lausanne
- HQ country
- Switzerland
- HQ region
- Europe
Offices5 records
Markets served
GenomSys business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- GenomSys MPEG-G Toolkit Licensing: SDK and command-line toolset for encoding, decoding, and managing genomic files in MPEG-G format. Available for on-premises installation and private cloud deployment for organizations implementing the ISO/IEC 23092 standard
- GenomSys Variant Analyzer Subscription: Clinical variant interpretation software supporting WES and WGS analysis with SNV, indel, and CNV detection, integrated with MPEG-G for end-to-end standard-compliant workflows. Offered as desktop application with trial requests
- GenomSys Blood Typer Licensing: First-of-its-kind software for genomic blood group characterization based on NGS data for blood transfusion centers - available for clinical testing and validation partnerships
- Regional Distribution Agreements: Exclusive software distribution partnerships in specific territories (e.g., Jordan with Genetics Company for Biotechnology) for regional market expansion
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise software licensing and subscription model |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
GenomSys product offering
Product offeringCore offering
GenomSys develops and licenses a unified software platform built on the ISO/IEC 23092 MPEG-G international standard for genomic data compression, storage, transmission, and analysis. Its portfolio includes an SDK/toolkit for encoding and decoding MPEG-G files, a cloud-based secondary analysis pipeline, a clinical variant interpretation desktop application, an NGS-based blood group typing software, and a consumer mobile app for personal genomic data access and sharing.
Product overview
GenomSys offers a unified MPEG-G-based software platform for genomic data management. The product portfolio consists of the GenomSys MPEG-G Toolkit (core SDK and command-line toolset for encoding/decoding/ managing MPEG-G genomic files), the GenomSys Secondary Analysis Platform (MPEG-G native cloud-based germline pipeline), the GenomSys Variant Analyzer (clinical variant interpretation desktop application for WES/WGS analysis), GenomSys Blood Typer (NGS-based blood group characterization software), and the GenomYou App (consumer genomics mobile application). All products leverage the ISO/IEC 23092 MPEG-G standard, enabling interoperability, dramatic compression (up to 77% smaller file sizes), and selective access to genomic data. The company is ISO-13485-certified as a manufacturer of software for medical devices.
Differentiator
Problem solved
Functional benefit
Brands
- GenomSys MPEG-G Toolkit: SDK and command-line toolset for encoding, decoding, and managing genomic files in MPEG-G format for bioinformatics pipeline integration.
- GenomSys Variant Analyzer
- GenomSys Blood Typer
- GenomSys Secondary Analysis
- GenomYou
Products and services
- GenomSys MPEG-G Toolkit SDK and command-line toolset that enables organizations to implement the ISO/IEC 23092 MPEG-G standard for encoding, decoding, and managing genomic sequencing data in their processing workflows, available on-premises and on private cloud.
- GenomSys Secondary Analysis Platform ISO/IEC 23092 MPEG-G native cloud-based germline pipeline that conducts secondary analysis for germline applications and enables automated compression and upload of genomic files directly from sequencing machines for downstream tertiary analysis.
- GenomSys Variant Analyzer (GVA) Germline analysis software natively operating in MPEG-G that supports Whole Exome Sequencing and Whole Genome Sequencing analysis with SNV, indel, and CNV detection, integrated with Varsome for variant annotation; targeted at clinical genetics laboratories for hereditary disease diagnostics.
- GenomSys Blood Typer First-of-its-kind software for high-throughput genomic characterization of 36 blood groups based on Next-Generation Sequencing data following International Society for Blood Transfusion standards, designed for blood transfusion centers to support transfusion compatibility and organ and stem cell transplantation.
- GenomYou App Consumer-facing mobile genomics application that enables individuals to access, understand, and securely share their personal genomic data in standardized MPEG-G format on their smartphones, supporting health and lifestyle decisions through integrated genetic counselling.
Quantifiable outcome
- 77% reduction in genomic file size vs BAM (lossless compression)
- +2 more outcomes
Companies that use GenomSys
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles5 records
GenomSys technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature6 records
GenomSys partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Genetics Company for BiotechnologycoreExclusive software distribution agreement in Jordan for MPEG-G solutions covering the Middle East region. Partnership focuses on MPEG-G standard adoption, preventive medicine software development, and clinical testing/validation of Blood Typer in Jordanian clinical environment.
- Philips HealthcarecoreStrategic cooperation integrating MPEG-G genomic data management into Philips health informatics portfolio. GenomSys contributes as recognized Healthcare Software Provider enabling hospitals and diagnostic centers to access standardized genomic solutions within enterprise-grade Philips infrastructure.
- Italian Institute of Technology (IIT)coreJoint laboratory collaboration validating MPEG-G on 5000genomi@VdA project with over 5,800 human genomes sequenced across five clinical cohorts. Collaboration includes Whole Genome Sequencing studies including 1,502 Parkinson's disease cases using AI-powered variant prioritization.
- SeqOneminorEurostars consortium partner focused on integration of MPEG-G in software suite for exome and genome interpretation.
- Institute of Medical Genomics (IMEGEN)minorEurostars consortium partner - biomedical genetics company providing testing environment for MPEG-G efficacy in medical genomics field.
- The Pirbright InstituteminorEurostars consortium partner - UK institute researching virus diseases of farm animals, introducing MPEG-G in animal science analysis pipeline.
- EPFLcoreHeadquarters at EPFL Innovation Park. Company co-founded with EPFL affiliations. Active in MPEG-G standard development with EPFL contributions.
- Vaud Economic DevelopmentminorSupported by Vaud canton economic development agency. Listed as company supported by Vaud.
Scale indicators6 records
Recent moves8 records
Expansion highlights5 records
GenomSys competitors and assessment
Company assessmentDirect peers
- DNAnexus: Cloud-based genomic data management and analysis platform serving pharma, clinical labs, and national genomics programs. Closely comparable to GenomSys's MPEG-G Toolkit and Secondary Analysis Platform in offering standards- and pipeline-oriented infrastructure for genomic data at scale.
- Velsera (formerly Seven Bridges Genomics): Bioinformatics platform providing secondary and tertiary analysis pipelines for clinical and research genomics customers. Direct comparable in delivering genomic analysis software into clinical labs and population genomics initiatives, similar go-to-market to GenomSys.
- SeqOne: Clinical genomics platform specializing in germline and somatic variant interpretation (exome/genome). Listed as a GenomSys Eurostars consortium partner integrating MPEG-G, and is the most direct head-to-head competitor for the GenomSys Variant Analyzer in hereditary disease diagnostics.
- Sophia Genetics: AI-powered clinical genomics platform used by hospital labs for somatic and germline variant interpretation. Direct comparable in selling clinical decision-support software into diagnostic laboratories globally, though at a significantly larger scale.
- Lifebit: Federated genomics and biomedical data analysis platform serving pharma, research consortia, and national genomics programs. Comparable in its focus on scalable, secure genomic data infrastructure — overlapping with GenomSys's secondary analysis and national health system play.
- BC Platforms: Genomic data management and biobanking platform serving national health systems, pharma, and research networks. Comparable in targeting population genomics and standardized genomic data infrastructure for large healthcare systems.
Broad incumbents
- Illumina (DRAGEN): Dominant sequencing platform vendor with DRAGEN secondary analysis and other software offerings that compete with GenomSys's Secondary Analysis Platform and Toolkit across most clinical and research genomics customers.
Emerging players
- Fabric Genomics (formerly Omicia): Clinical genomics interpretation platform focused on rare disease and hereditary disease variant analysis. Comparable to the GenomSys Variant Analyzer use case in hereditary diagnostics, though with a narrower commercial footprint.
- Congenica: Clinical genomic analysis platform for rare disease and hereditary disorder interpretation, used by national genomics programs. Comparable to GenomSys Variant Analyzer in germline analysis for hereditary diagnostics.
- FDNA: Genomics and AI-driven phenotyping platform integrating facial and genomic analysis for rare disease diagnosis. Adjacent player serving similar diagnostic laboratory customers with complementary genomics-based decision support.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
GenomSys social profiles
Digital presenceGenomSys compliance and trust
Trust signalCompliance1 record
GenomSys financial estimates
Financial estimateRevenue estimate
Valuation estimate
GenomSys leadership team
Management profileNumber of profiles
Profiles4 records
GenomSys subsidiaries and ownership
Company hierarchySubsidiaries1 record
GenomSys funding detail
Funding detailFunding overview
Funding rounds3 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GenomSys M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GenomSys
What does GenomSys do?
GenomSys develops and licenses a unified software platform built on the ISO/IEC 23092 MPEG-G international standard for genomic data compression, storage, transmission, and analysis. Its portfolio includes an SDK/toolkit for encoding and decoding MPEG-G files, a cloud-based secondary analysis pipeline, a clinical variant interpretation desktop application, an NGS-based blood group typing software, and a consumer mobile app for personal genomic data access and sharing.
Is GenomSys a public or private company?
GenomSys is a private company. It is classified as venture growth investor backed and is currently operating.
When was GenomSys founded?
GenomSys was founded in 2016. It employs 11 to 50 people.
Where is GenomSys based?
GenomSys is headquartered in Lausanne, Switzerland, in the Europe region.
How does GenomSys make money?
Four revenue lines are on record. GenomSys MPEG-G Toolkit Licensing is the primary driver. The others are genomSys Variant Analyzer Subscription, genomSys Blood Typer Licensing and regional Distribution Agreements.
Who are GenomSys's main competitors?
Direct peers on record are DNAnexus, Velsera (formerly Seven Bridges Genomics), SeqOne, Sophia Genetics, Lifebit and BC Platforms. Illumina (DRAGEN) is listed as a broad incumbent. Emerging players are Fabric Genomics (formerly Omicia), Congenica and FDNA.
Does GenomSys have an API?
No public API is recorded for GenomSys.
What industry is GenomSys in?
GenomSys's product category is Genomic Data Management Software. Its primary akta.pro industry code is HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics), with a secondary code of HLAAANAL, Population Genomics & Preventive Precision Health Programs. Its NAICS code is 5132 and its SIC code is 7372.